Senior insider sale
Chief Accounting Officer at KALARIS THERAPEUTICS, INC. — senior position signals high conviction
$2.0K
159.00 shares
What this filing means
HAGEN BRETT R plans to sell 159.00 shares of KALARIS THERAPEUTICS, INC. valued at approximately $2.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/24/2025ACC: 0000950170-25-025332
Officer· Chief Accounting Officer
Since Jul 2020
159.00
Shares to sell
$2.0K
Approx. market value
96.00
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Restricted Stock
N/A
2/21/2025
96.00Total acquired96.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/21/2025 | Restricted Stock N/A | 96.00 | — |
| Total | 96.00 | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
36.00
Market value
$341.00
1/23/2025
—Completed
Units to sell
14.00
Market value
$146.00
1/10/2025
—Completed
Units to sell
13.00
Market value
$554.00
11/19/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
96.00
Market value
$967.00
2/21/2025
Total
Units
159.00
Value
$2.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/23/2025 | 36.00 | $341.00 | — | Completed |
1/10/2025 | 14.00 | $146.00 | — | Completed |
11/19/2024 | 13.00 | $554.00 | — | Completed |
| Planned — Approximate Date | ||||
2/21/2025 | 96.00 | $967.00 | NASDAQ | Planned |
| Total | 159.00 | $2.0K | ||